| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0086 | 0.9 |